Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

5-methoxy-6-methyl-2-aminoindan

Known as: 5-MMAI 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Serotonin (5-hydroxytryptamine, 5-HT)-releasing drugs are important experimental tools to examine the role of serotonergic nerve… Expand
Highly Cited
1996
Highly Cited
1996
The present study was designed to characterize further the rewarding and aversive properties of 3,4-methylenedioxymethamphetamine… Expand
Highly Cited
1995
Highly Cited
1995
LLC-PK1 cells have been stably transfected with cDNAs encoding the human norepinephrine transporter (NET), rat dopamine… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
Highly Cited
1995
Highly Cited
1995
The present study was undertaken to compare the pharmacological properties of p-fluoroamphetamine with those of amphetamine and… Expand
1994
1994
The behavioral effects of 5-methoxy-6-methyl-2-aminoindan (MMAI) were examined using the drug discrimination procedure and direct… Expand
1993
1993
The hypothesis was tested that serotonin (5-HT) modulates 3,4-methylenedioxymethamphetamine (MDMA)-induced increase in dopamine… Expand
Highly Cited
1993
Highly Cited
1993
3,4-Methylenedioxymethamphetamine (MDMA) and several other amphetamine derivatives cause degeneration of serotonergic nerve… Expand
Highly Cited
1992
Highly Cited
1992
p-Methylthioamphetamine (MTA), was compared to p-chloroamphetamine (PCA) in a number of pharmacological assays. MTA was about 2… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
1991
1991
The racemate and the enantiomers of 1-(3-methoxy-4-methyphenyl)-2- aminopropane (6) and racemic 5-methoxy-6-methyl-2-aminoindan… Expand
Highly Cited
1991
Highly Cited
1991
The ability of several 3,4-methylenedioxymethamphetamine (MDMA) analogues to inhibit the uptake of [3H]serotonin (5-HT), dopamine… Expand